334 related articles for article (PubMed ID: 25682942)
41. Pediatric inflammatory myofibroblastic tumor of the bladder with ALK-FN1 fusion successfully treated by alectinib.
Fujiki T; Sakai Y; Ikawa Y; Takenaka M; Noguchi K; Kuroda R; Abe T; Nomura K; Sakai S; Wada T
Pediatr Blood Cancer; 2023 Apr; 70(4):e30172. PubMed ID: 36635892
[TBL] [Abstract][Full Text] [Related]
42. A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.
Kimbara S; Takeda K; Fukushima H; Inoue T; Okada H; Shibata Y; Katsushima U; Tsuya A; Tokunaga S; Daga H; Okuno T; Inoue T
Jpn J Clin Oncol; 2014 Sep; 44(9):868-71. PubMed ID: 25028698
[TBL] [Abstract][Full Text] [Related]
43. Myofibroblastic tumours: neoplasias with divergent behaviour. Ultrastructural and flow cytometric analysis.
Biselli R; Boldrini R; Ferlini C; Boglino C; Inserra A; Bosman C
Pathol Res Pract; 1999; 195(9):619-32. PubMed ID: 10507082
[TBL] [Abstract][Full Text] [Related]
44. Inflammatory myofibroblastic tumor of the central nervous system: clinicopathologic analysis of 10 cases.
Jeon YK; Chang KH; Suh YL; Jung HW; Park SH
J Neuropathol Exp Neurol; 2005 Mar; 64(3):254-9. PubMed ID: 15804057
[TBL] [Abstract][Full Text] [Related]
45. Inflammatory myofibroblastic tumor of the lung in children: anaplastic lymphoma kinase (ALK) expression and clinico-pathological correlation.
Siminovich M; Galluzzo L; López J; Lubieniecki F; de Dávila MT
Pediatr Dev Pathol; 2012; 15(3):179-86. PubMed ID: 22280150
[TBL] [Abstract][Full Text] [Related]
46. RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors.
Patel AS; Murphy KM; Hawkins AL; Cohen JS; Long PP; Perlman EJ; Griffin CA
Cancer Genet Cytogenet; 2007 Jul; 176(2):107-14. PubMed ID: 17656252
[TBL] [Abstract][Full Text] [Related]
47. Inflammatory myofibroblastic tumors of the urinary bladder: a systematic review.
Teoh JY; Chan NH; Cheung HY; Hou SS; Ng CF
Urology; 2014 Sep; 84(3):503-8. PubMed ID: 25168523
[TBL] [Abstract][Full Text] [Related]
48. ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor.
Debiec-Rychter M; Marynen P; Hagemeijer A; Pauwels P
Genes Chromosomes Cancer; 2003 Oct; 38(2):187-90. PubMed ID: 12939746
[TBL] [Abstract][Full Text] [Related]
49. ALK-1 positive orbital inflammatory myofibroblastic tumour (IMT) associated with prominent numbers of IgG4 plasma cells - a case report.
Mudhar HS; Nuruddin M
Orbit; 2013 Oct; 32(5):321-3. PubMed ID: 23927068
[TBL] [Abstract][Full Text] [Related]
50. ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects.
Brivio E; Zwaan CM
Pediatr Blood Cancer; 2019 May; 66(5):e27645. PubMed ID: 30697903
[TBL] [Abstract][Full Text] [Related]
51. Inflammatory myofibroblastic tumor of the esophagus in childhood: a case report and a review of the literature.
Dousek R; Tuma J; Planka L; Husek K; Sterba J; Penka I
J Pediatr Hematol Oncol; 2015 Mar; 37(2):e121-4. PubMed ID: 25354253
[TBL] [Abstract][Full Text] [Related]
52. Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targets.
Vernemmen AIP; Samarska IV; Speel EM; Riedl RG; Goudkade D; de Bruïne AP; Wouda S; van Marion AM; Verlinden IV; van Lijnschoten I; Friederich P; Winnepenninckx VJL; Zur Hausen A; Sciot RME; van den Hout MFCM
Histopathology; 2024 Apr; 84(5):794-809. PubMed ID: 38155480
[TBL] [Abstract][Full Text] [Related]
53. HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma.
Hong M; Kim RN; Song JY; Choi SJ; Oh E; Lira ME; Mao M; Takeuchi K; Han J; Kim J; Choi YL
J Thorac Oncol; 2014 Mar; 9(3):419-22. PubMed ID: 24518094
[TBL] [Abstract][Full Text] [Related]
54. A newborn case of jejunal ALK-negative inflammatory myofibroblastic tumor with ETV6-NTRK3 fusion.
Masuda Y; Tsukamoto Y; Zenitani M; Oda Y; Kinoshita I; Kohashi K; Takemoto J; Hirota S; Shibata A; Koda T; Takeshima Y
Pediatr Blood Cancer; 2019 Oct; 66(10):e27902. PubMed ID: 31250485
[No Abstract] [Full Text] [Related]
55. An isolated inflammatory myofibroblastic tumor of adrenal gland.
Al Sannaa G; Wimmer JL; Ayala AG; Ro JY
Ann Diagn Pathol; 2016 Dec; 25():33-36. PubMed ID: 27806843
[TBL] [Abstract][Full Text] [Related]
56. Spectrum of kinase gene rearrangements in a large series of paediatric inflammatory myofibroblastic tumours.
Preobrazhenskaya EV; Suleymanova AM; Bizin IV; Zagrebin FA; Romanko AA; Saitova ES; Mulkidzhan RS; Imyanitov EN
Histopathology; 2023 Jul; 83(1):109-115. PubMed ID: 37071060
[TBL] [Abstract][Full Text] [Related]
57. ALK-positive inflammatory myofibroblastic tumor of the abdomen with widespread microscopic multifocality.
Lorenzi L; Cigognetti M; Medicina D; Pellegrini V; Balzarini P; Cestari R; Facchetti F
Int J Surg Pathol; 2014 Oct; 22(7):640-4. PubMed ID: 24583837
[TBL] [Abstract][Full Text] [Related]
58. HIP1-ALK, a novel ALK fusion variant that responds to crizotinib.
Fang DD; Zhang B; Gu Q; Lira M; Xu Q; Sun H; Qian M; Sheng W; Ozeck M; Wang Z; Zhang C; Chen X; Chen KX; Li J; Chen SH; Christensen J; Mao M; Chan CC
J Thorac Oncol; 2014 Mar; 9(3):285-94. PubMed ID: 24496003
[TBL] [Abstract][Full Text] [Related]
59. Low-grade myofibroblastic proliferations of the urinary bladder.
Alquati S; Gira FA; Bartoli V; Contini S; Corradi D
Arch Pathol Lab Med; 2013 Aug; 137(8):1117-28. PubMed ID: 23899070
[TBL] [Abstract][Full Text] [Related]
60. An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features.
Chen ST; Lee JC
Hum Pathol; 2008 Dec; 39(12):1854-8. PubMed ID: 18701132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]